Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
CNY 7.72
(-5.28%)
CNY 7.72
(-5.28%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 159.58 Million CNY | 0.78% |
| 2022 | 158.35 Million CNY | 1382.08% |
| 2021 | -12.35 Million CNY | -111.56% |
| 2020 | 106.83 Million CNY | 467.97% |
| 2019 | -29.03 Million CNY | -125.94% |
| 2018 | 111.93 Million CNY | -21.32% |
| 2017 | 142.27 Million CNY | -10.24% |
| 2016 | 158.51 Million CNY | 38.58% |
| 2015 | 114.38 Million CNY | 25.86% |
| 2014 | 90.88 Million CNY | 65.99% |
| 2013 | 54.75 Million CNY | -14.44% |
| 2012 | 63.99 Million CNY | 46.85% |
| 2011 | 43.57 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 34.74 Million CNY | 317.92% |
| 2024 Q2 | -5.26 Million CNY | -115.16% |
| 2024 Q3 | 59.17 Million CNY | 1223.22% |
| 2023 Q4 | -15.94 Million CNY | 27.35% |
| 2023 FY | 159.58 Million CNY | 0.78% |
| 2023 Q1 | 198.1 Million CNY | 237.42% |
| 2023 Q2 | -628.76 Thousand CNY | -100.32% |
| 2023 Q3 | -21.94 Million CNY | -3390.81% |
| 2022 Q4 | 58.71 Million CNY | -57.58% |
| 2022 FY | 158.35 Million CNY | 1382.08% |
| 2022 Q3 | 138.4 Million CNY | 1096.58% |
| 2022 Q2 | -13.88 Million CNY | -136.34% |
| 2022 Q1 | 38.21 Million CNY | -63.24% |
| 2021 FY | -12.35 Million CNY | -111.56% |
| 2021 Q2 | -30.89 Million CNY | -171.14% |
| 2021 Q3 | -61.53 Million CNY | -99.19% |
| 2021 Q1 | 43.42 Million CNY | -36.41% |
| 2021 Q4 | 103.97 Million CNY | 268.96% |
| 2020 Q1 | 74.65 Million CNY | 157.78% |
| 2020 Q3 | 64.49 Million CNY | 448.98% |
| 2020 Q2 | -18.48 Million CNY | -124.76% |
| 2020 FY | 106.83 Million CNY | 467.97% |
| 2020 Q4 | 68.29 Million CNY | 5.89% |
| 2019 Q3 | -10.14 Million CNY | 42.82% |
| 2019 Q2 | -17.73 Million CNY | -126.35% |
| 2019 Q1 | 67.32 Million CNY | 1016.38% |
| 2019 FY | -29.03 Million CNY | -125.94% |
| 2019 Q4 | 28.95 Million CNY | 385.55% |
| 2018 Q3 | 71.65 Million CNY | 240.04% |
| 2018 FY | 111.93 Million CNY | -21.32% |
| 2018 Q1 | 88.24 Million CNY | 136.26% |
| 2018 Q4 | 6.03 Million CNY | -91.58% |
| 2018 Q2 | -51.16 Million CNY | -157.98% |
| 2017 Q1 | 50.23 Million CNY | 29.34% |
| 2017 FY | 142.27 Million CNY | -10.24% |
| 2017 Q3 | 41.07 Million CNY | 201.9% |
| 2017 Q4 | 37.35 Million CNY | -9.07% |
| 2017 Q2 | 13.6 Million CNY | -72.92% |
| 2016 Q3 | 44.52 Million CNY | 498.74% |
| 2016 FY | 158.51 Million CNY | 38.58% |
| 2016 Q4 | 38.84 Million CNY | -12.77% |
| 2016 Q2 | -11.16 Million CNY | -112.94% |
| 2016 Q1 | 86.3 Million CNY | 82.67% |
| 2015 Q2 | -7.83 Million CNY | -116.8% |
| 2015 Q1 | 46.62 Million CNY | 33.58% |
| 2015 FY | 114.38 Million CNY | 25.86% |
| 2015 Q4 | 47.24 Million CNY | 66.71% |
| 2015 Q3 | 28.34 Million CNY | 461.72% |
| 2014 FY | 90.88 Million CNY | 65.99% |
| 2014 Q3 | 21.22 Million CNY | 227.21% |
| 2014 Q1 | 51.43 Million CNY | 0.0% |
| 2014 Q4 | 34.9 Million CNY | 64.49% |
| 2014 Q2 | -16.68 Million CNY | -132.43% |
| 2013 FY | 54.75 Million CNY | -14.44% |
| 2012 FY | 63.99 Million CNY | 46.85% |
| 2011 FY | 43.57 Million CNY | 0.0% |